Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
Federal Trade Commission
Cantor Fitzgerald
Fuji
Fish and Richardson
Argus Health
Farmers Insurance
Citi

Generated: June 22, 2018

DrugPatentWatch Database Preview

ALUPENT Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Alupent, and when can generic versions of Alupent launch?

Alupent is a drug marketed by Boehringer Ingelheim and is included in five NDAs.

The generic ingredient in ALUPENT is metaproterenol sulfate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the metaproterenol sulfate profile page.
Summary for ALUPENT
Drug patent expirations by year for ALUPENT
Medical Subject Heading (MeSH) Categories for ALUPENT
Synonyms for ALUPENT
(RS)-1-(3,5-Dihydroxyphenyl)-2-isopropylaminoethanol
[2-(3,5-Dihydroxy-phenyl)-2-hydroxy-ethyl]-isopropyl-ammonium
[2-(3,5-Dihydroxy-phenyl)-2-hydroxy-ethyl]-isopropyl-ammonium (orciprenaline)
1-(3,5-Dihydroxyphenyl)-2-isopropylaminoethanol
1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-
1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)- (9CI)
1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-(9CI)
1,3-Benzenediol, 5-[(1R)-1-hydroxy-2-[(1-methylethyl)amino]ethyl]-
1,3-Benzenediol, 5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-
3,5-Dihydroxy-.alpha.-((isopropylamino)methyl)benzyl alcohol
3,5-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol
3,5-dihydroxy-alpha-[(isopropylamino)methyl]benzenemethanol
3B1-006410
5-(1-Hydroxy-2-(isopropylamino)ethyl)benzene-1,3-diol
5-(1-Hydroxy-2-isopropylamino-ethyl)-benzene-1,3-diol
5-(1-Hydroxy-2-propan-2-ylamino-ethyl)benzene-1,3-diol
5-[1-hydroxy-2-(1-methylethylamino)ethyl]benzene-1,3-diol
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol
5-[1-Hydroxy-2-(isopropylamino)ethyl]-1,3-benzenediol #
5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol
5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol
5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol
5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol, 6
586-06-1
586O061
99396-41-5
AB00052037
AB00052037_09
AB00052037_10
AC1L1HDP
ACMC-20m2sn
AK395737
AKOS022506181
Alotec
Alotec (TN)
Alupent (TN)
AN-46122
API0006235
Astmopent
BDBM50295572
Benzyl alcohol, 3,5-dihydroxy-.alpha.-((isopropylamino)methyl)-
Benzyl alcohol, 3,5-dihydroxy-alpha-((isopropylamino)methyl)-
BPBio1_000473
BRN 2807247
BSPBio_000429
BSPBio_001983
C07144
CCG-38914
CCRIS 9017
CHEBI:6792
CHEBI:83329
CHEMBL776
CPD001453712
D02UFG
D08300
D0Y2MV
DB00816
DivK1c_000645
DR000368
DTXSID8048529
EINECS 209-569-1
EN300-142650
GTPL7250
HMS1920L09
HMS2091D04
HMS3259J13
HMS502A07
IDI1_000645
KBio1_000645
KBio2_001405
KBio2_003973
KBio2_006541
KBio3_001483
KBioGR_000507
KBioSS_001405
L000678
LMOINURANNBYCM-UHFFFAOYSA-N
Lopac0_000734
LS-42870
M-3070
MCULE-8722254342
Metaprel
Metaprel (TN)
metaproterenol
Metaproterenol polistirex
Metaproterenol Polistirex (metaproterenol)
Metaproterenol sulfate
NC00651
NCGC00015655-02
NCGC00015655-03
NCGC00015655-04
NCGC00015655-05
NCGC00015655-06
NCGC00094718-01
NCGC00094718-02
NCGC00094718-03
NINDS_000645
Novasmasol
Novasmasol (TN)
NSC-757089
NSC757089
OR113153
OR289886
Orciprenalin
Orciprenalina
Orciprenalina [INN-Spanish]
ORCIPRENALINE
Orciprenaline (INN)
Orciprenaline [INN:BAN]
Orciprenaline [INN]
Orciprenaline sulfate
Orciprenalinum
Orciprenalinum [INN-Latin]
Pharmakon1600-01500390
Prestwick0_000505
Prestwick1_000505
Prestwick2_000505
Prestwick3_000505
Prometa
SAM002548965
SBI-0050712.P004
SCHEMBL4270
SPBio_000052
SPBio_002350
Spectrum_000925
SPECTRUM1500390
Spectrum2_000096
Spectrum3_000492
Spectrum4_000044
Spectrum5_000952
SR-01000075168
SR-01000075168-1
TH-152

US Patents and Regulatory Information for ALUPENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim ALUPENT metaproterenol sulfate AEROSOL, METERED;INHALATION 016402-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim ALUPENT metaproterenol sulfate TABLET;ORAL 015874-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 017659-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 018761-002 Oct 10, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for ALUPENT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim ALUPENT metaproterenol sulfate SYRUP;ORAL 017571-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim ALUPENT metaproterenol sulfate TABLET;ORAL 015874-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim ALUPENT metaproterenol sulfate AEROSOL, METERED;INHALATION 016402-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim ALUPENT metaproterenol sulfate TABLET;ORAL 015874-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Express Scripts
Teva
AstraZeneca
Chinese Patent Office
Merck
Chubb
McKinsey
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.